HPV Diagnostic Product Market, Global Outlook and Forecast 2022-2028

April 2022 | 104 pages | ID: H576BA2A3DF0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of HPV Diagnostic Product in Global, including the following market information:

Global HPV Diagnostic Product Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HPV Diagnostic Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

In Situ Hybridization Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HPV Diagnostic Product include Qiagen, Thermo Fisher Scientific, Abbott, Roche, Hologic, Cepheid, Takara Bio, DaAn Gene and Promega, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HPV Diagnostic Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HPV Diagnostic Product Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HPV Diagnostic Product Market Segment Percentages, by Type, 2021 (%)

• In Situ Hybridization
• HC2 Technology
• PCR

Global HPV Diagnostic Product Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HPV Diagnostic Product Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Others

Global HPV Diagnostic Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HPV Diagnostic Product Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HPV Diagnostic Product revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HPV Diagnostic Product revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Qiagen
• Thermo Fisher Scientific
• Abbott
• Roche
• Hologic
• Cepheid
• Takara Bio
• DaAn Gene
• Promega
• HPV Diagnostic
• Enzo Biochem
• Norgen Biotek
• DiagCor Bioscience
• Hybribio
• Zytovision
• Medical & Biological Laboratories
• Fujirebio Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HPV Diagnostic Product Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HPV Diagnostic Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HPV DIAGNOSTIC PRODUCT OVERALL MARKET SIZE

2.1 Global HPV Diagnostic Product Market Size: 2021 VS 2028
2.2 Global HPV Diagnostic Product Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HPV Diagnostic Product Players in Global Market
3.2 Top Global HPV Diagnostic Product Companies Ranked by Revenue
3.3 Global HPV Diagnostic Product Revenue by Companies
3.4 Top 3 and Top 5 HPV Diagnostic Product Companies in Global Market, by Revenue in 2021
3.5 Global Companies HPV Diagnostic Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 HPV Diagnostic Product Players in Global Market
  3.6.1 List of Global Tier 1 HPV Diagnostic Product Companies
  3.6.2 List of Global Tier 2 and Tier 3 HPV Diagnostic Product Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HPV Diagnostic Product Market Size Markets, 2021 & 2028
  4.1.2 In Situ Hybridization
  4.1.3 HC2 Technology
  4.1.4 PCR
4.2 By Type - Global HPV Diagnostic Product Revenue & Forecasts
  4.2.1 By Type - Global HPV Diagnostic Product Revenue, 2017-2022
  4.2.2 By Type - Global HPV Diagnostic Product Revenue, 2023-2028
  4.2.3 By Type - Global HPV Diagnostic Product Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HPV Diagnostic Product Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global HPV Diagnostic Product Revenue & Forecasts
  5.2.1 By Application - Global HPV Diagnostic Product Revenue, 2017-2022
  5.2.2 By Application - Global HPV Diagnostic Product Revenue, 2023-2028
  5.2.3 By Application - Global HPV Diagnostic Product Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HPV Diagnostic Product Market Size, 2021 & 2028
6.2 By Region - Global HPV Diagnostic Product Revenue & Forecasts
  6.2.1 By Region - Global HPV Diagnostic Product Revenue, 2017-2022
  6.2.2 By Region - Global HPV Diagnostic Product Revenue, 2023-2028
  6.2.3 By Region - Global HPV Diagnostic Product Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HPV Diagnostic Product Revenue, 2017-2028
  6.3.2 US HPV Diagnostic Product Market Size, 2017-2028
  6.3.3 Canada HPV Diagnostic Product Market Size, 2017-2028
  6.3.4 Mexico HPV Diagnostic Product Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HPV Diagnostic Product Revenue, 2017-2028
  6.4.2 Germany HPV Diagnostic Product Market Size, 2017-2028
  6.4.3 France HPV Diagnostic Product Market Size, 2017-2028
  6.4.4 U.K. HPV Diagnostic Product Market Size, 2017-2028
  6.4.5 Italy HPV Diagnostic Product Market Size, 2017-2028
  6.4.6 Russia HPV Diagnostic Product Market Size, 2017-2028
  6.4.7 Nordic Countries HPV Diagnostic Product Market Size, 2017-2028
  6.4.8 Benelux HPV Diagnostic Product Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HPV Diagnostic Product Revenue, 2017-2028
  6.5.2 China HPV Diagnostic Product Market Size, 2017-2028
  6.5.3 Japan HPV Diagnostic Product Market Size, 2017-2028
  6.5.4 South Korea HPV Diagnostic Product Market Size, 2017-2028
  6.5.5 Southeast Asia HPV Diagnostic Product Market Size, 2017-2028
  6.5.6 India HPV Diagnostic Product Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HPV Diagnostic Product Revenue, 2017-2028
  6.6.2 Brazil HPV Diagnostic Product Market Size, 2017-2028
  6.6.3 Argentina HPV Diagnostic Product Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HPV Diagnostic Product Revenue, 2017-2028
  6.7.2 Turkey HPV Diagnostic Product Market Size, 2017-2028
  6.7.3 Israel HPV Diagnostic Product Market Size, 2017-2028
  6.7.4 Saudi Arabia HPV Diagnostic Product Market Size, 2017-2028
  6.7.5 UAE HPV Diagnostic Product Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Qiagen
  7.1.1 Qiagen Corporate Summary
  7.1.2 Qiagen Business Overview
  7.1.3 Qiagen HPV Diagnostic Product Major Product Offerings
  7.1.4 Qiagen HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.1.5 Qiagen Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific HPV Diagnostic Product Major Product Offerings
  7.2.4 Thermo Fisher Scientific HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott HPV Diagnostic Product Major Product Offerings
  7.3.4 Abbott HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.3.5 Abbott Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche HPV Diagnostic Product Major Product Offerings
  7.4.4 Roche HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Hologic
  7.5.1 Hologic Corporate Summary
  7.5.2 Hologic Business Overview
  7.5.3 Hologic HPV Diagnostic Product Major Product Offerings
  7.5.4 Hologic HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.5.5 Hologic Key News
7.6 Cepheid
  7.6.1 Cepheid Corporate Summary
  7.6.2 Cepheid Business Overview
  7.6.3 Cepheid HPV Diagnostic Product Major Product Offerings
  7.6.4 Cepheid HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.6.5 Cepheid Key News
7.7 Takara Bio
  7.7.1 Takara Bio Corporate Summary
  7.7.2 Takara Bio Business Overview
  7.7.3 Takara Bio HPV Diagnostic Product Major Product Offerings
  7.7.4 Takara Bio HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.7.5 Takara Bio Key News
7.8 DaAn Gene
  7.8.1 DaAn Gene Corporate Summary
  7.8.2 DaAn Gene Business Overview
  7.8.3 DaAn Gene HPV Diagnostic Product Major Product Offerings
  7.8.4 DaAn Gene HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.8.5 DaAn Gene Key News
7.9 Promega
  7.9.1 Promega Corporate Summary
  7.9.2 Promega Business Overview
  7.9.3 Promega HPV Diagnostic Product Major Product Offerings
  7.9.4 Promega HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.9.5 Promega Key News
7.10 HPV Diagnostic
  7.10.1 HPV Diagnostic Corporate Summary
  7.10.2 HPV Diagnostic Business Overview
  7.10.3 HPV Diagnostic HPV Diagnostic Product Major Product Offerings
  7.10.4 HPV Diagnostic HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.10.5 HPV Diagnostic Key News
7.11 Enzo Biochem
  7.11.1 Enzo Biochem Corporate Summary
  7.11.2 Enzo Biochem Business Overview
  7.11.3 Enzo Biochem HPV Diagnostic Product Major Product Offerings
  7.11.4 Enzo Biochem HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.11.5 Enzo Biochem Key News
7.12 Norgen Biotek
  7.12.1 Norgen Biotek Corporate Summary
  7.12.2 Norgen Biotek Business Overview
  7.12.3 Norgen Biotek HPV Diagnostic Product Major Product Offerings
  7.12.4 Norgen Biotek HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.12.5 Norgen Biotek Key News
7.13 DiagCor Bioscience
  7.13.1 DiagCor Bioscience Corporate Summary
  7.13.2 DiagCor Bioscience Business Overview
  7.13.3 DiagCor Bioscience HPV Diagnostic Product Major Product Offerings
  7.13.4 DiagCor Bioscience HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.13.5 DiagCor Bioscience Key News
7.14 Hybribio
  7.14.1 Hybribio Corporate Summary
  7.14.2 Hybribio Business Overview
  7.14.3 Hybribio HPV Diagnostic Product Major Product Offerings
  7.14.4 Hybribio HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.14.5 Hybribio Key News
7.15 Zytovision
  7.15.1 Zytovision Corporate Summary
  7.15.2 Zytovision Business Overview
  7.15.3 Zytovision HPV Diagnostic Product Major Product Offerings
  7.15.4 Zytovision HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.15.5 Zytovision Key News
7.16 Medical & Biological Laboratories
  7.16.1 Medical & Biological Laboratories Corporate Summary
  7.16.2 Medical & Biological Laboratories Business Overview
  7.16.3 Medical & Biological Laboratories HPV Diagnostic Product Major Product Offerings
  7.16.4 Medical & Biological Laboratories HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.16.5 Medical & Biological Laboratories Key News
7.17 Fujirebio Diagnostics
  7.17.1 Fujirebio Diagnostics Corporate Summary
  7.17.2 Fujirebio Diagnostics Business Overview
  7.17.3 Fujirebio Diagnostics HPV Diagnostic Product Major Product Offerings
  7.17.4 Fujirebio Diagnostics HPV Diagnostic Product Revenue in Global Market (2017-2022)
  7.17.5 Fujirebio Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HPV Diagnostic Product Market Opportunities & Trends in Global Market
Table 2. HPV Diagnostic Product Market Drivers in Global Market
Table 3. HPV Diagnostic Product Market Restraints in Global Market
Table 4. Key Players of HPV Diagnostic Product in Global Market
Table 5. Top HPV Diagnostic Product Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HPV Diagnostic Product Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HPV Diagnostic Product Revenue Share by Companies, 2017-2022
Table 8. Global Companies HPV Diagnostic Product Product Type
Table 9. List of Global Tier 1 HPV Diagnostic Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HPV Diagnostic Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HPV Diagnostic Product Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HPV Diagnostic Product Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HPV Diagnostic Product Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HPV Diagnostic Product Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HPV Diagnostic Product Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HPV Diagnostic Product Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HPV Diagnostic Product Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HPV Diagnostic Product Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HPV Diagnostic Product Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HPV Diagnostic Product Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HPV Diagnostic Product Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HPV Diagnostic Product Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HPV Diagnostic Product Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HPV Diagnostic Product Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HPV Diagnostic Product Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HPV Diagnostic Product Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HPV Diagnostic Product Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HPV Diagnostic Product Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HPV Diagnostic Product Revenue, (US$, Mn), 2023-2028
Table 30. Qiagen Corporate Summary
Table 31. Qiagen HPV Diagnostic Product Product Offerings
Table 32. Qiagen HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific HPV Diagnostic Product Product Offerings
Table 35. Thermo Fisher Scientific HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott HPV Diagnostic Product Product Offerings
Table 38. Abbott HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche HPV Diagnostic Product Product Offerings
Table 41. Roche HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 42. Hologic Corporate Summary
Table 43. Hologic HPV Diagnostic Product Product Offerings
Table 44. Hologic HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 45. Cepheid Corporate Summary
Table 46. Cepheid HPV Diagnostic Product Product Offerings
Table 47. Cepheid HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 48. Takara Bio Corporate Summary
Table 49. Takara Bio HPV Diagnostic Product Product Offerings
Table 50. Takara Bio HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 51. DaAn Gene Corporate Summary
Table 52. DaAn Gene HPV Diagnostic Product Product Offerings
Table 53. DaAn Gene HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 54. Promega Corporate Summary
Table 55. Promega HPV Diagnostic Product Product Offerings
Table 56. Promega HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 57. HPV Diagnostic Corporate Summary
Table 58. HPV Diagnostic HPV Diagnostic Product Product Offerings
Table 59. HPV Diagnostic HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 60. Enzo Biochem Corporate Summary
Table 61. Enzo Biochem HPV Diagnostic Product Product Offerings
Table 62. Enzo Biochem HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 63. Norgen Biotek Corporate Summary
Table 64. Norgen Biotek HPV Diagnostic Product Product Offerings
Table 65. Norgen Biotek HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 66. DiagCor Bioscience Corporate Summary
Table 67. DiagCor Bioscience HPV Diagnostic Product Product Offerings
Table 68. DiagCor Bioscience HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 69. Hybribio Corporate Summary
Table 70. Hybribio HPV Diagnostic Product Product Offerings
Table 71. Hybribio HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 72. Zytovision Corporate Summary
Table 73. Zytovision HPV Diagnostic Product Product Offerings
Table 74. Zytovision HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 75. Medical & Biological Laboratories Corporate Summary
Table 76. Medical & Biological Laboratories HPV Diagnostic Product Product Offerings
Table 77. Medical & Biological Laboratories HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)
Table 78. Fujirebio Diagnostics Corporate Summary
Table 79. Fujirebio Diagnostics HPV Diagnostic Product Product Offerings
Table 80. Fujirebio Diagnostics HPV Diagnostic Product Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HPV Diagnostic Product Segment by Type in 2021
Figure 2. HPV Diagnostic Product Segment by Application in 2021
Figure 3. Global HPV Diagnostic Product Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HPV Diagnostic Product Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HPV Diagnostic Product Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HPV Diagnostic Product Revenue in 2021
Figure 8. By Type - Global HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 9. By Application - Global HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 10. By Region - Global HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 11. By Country - North America HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 12. US HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 16. Germany HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 17. France HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 24. China HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 28. India HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 30. Brazil HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HPV Diagnostic Product Revenue Market Share, 2017-2028
Figure 33. Turkey HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HPV Diagnostic Product Revenue, (US$, Mn), 2017-2028
Figure 37. Qiagen HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hologic HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cepheid HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takara Bio HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DaAn Gene HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Promega HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. HPV Diagnostic HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Enzo Biochem HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Norgen Biotek HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. DiagCor Bioscience HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hybribio HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Zytovision HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Medical & Biological Laboratories HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Fujirebio Diagnostics HPV Diagnostic Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)